News
Takara Bio Europe has signed a strategic distribution agreement with MACHEREY-NAGEL, opening up new commercial opportunities ...
Asahi Kasei Pharma has commenced a Phase III clinical trial in Japan to evaluate ART-123 (thrombomodulin alfa; marketed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results